These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35929273)

  • 1. Gemini surfactant-based nanoparticles T-box1 gene delivery as a novel approach to promote epithelial stem cells differentiation and dental enamel formation.
    Mohabatpour F; Al-Dulaymi M; Lobanova L; Scutchings B; Papagerakis S; Badea I; Chen X; Papagerakis P
    Biomater Adv; 2022 Jun; 137():212844. PubMed ID: 35929273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
    Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
    J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
    Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
    J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-Modified Gemini Surfactants: Preparation and Characterization for Gene Delivery.
    Al-Dulaymi M; Mohammed-Saeid W; El-Aneed A; Badea I
    Methods Mol Biol; 2019; 2000():203-225. PubMed ID: 31148017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity.
    Al-Dulaymi MA; Chitanda JM; Mohammed-Saeid W; Araghi HY; Verrall RE; Grochulski P; Badea I
    AAPS J; 2016 Sep; 18(5):1168-1181. PubMed ID: 27184577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.
    Jin W; Al-Dulaymi M; Badea I; Leary SC; Rehman J; El-Aneed A
    AAPS J; 2019 Aug; 21(5):98. PubMed ID: 31388860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.
    Singh J; Yang P; Michel D; Verrall RE; Foldvari M; Badea I
    Curr Drug Deliv; 2011 May; 8(3):299-306. PubMed ID: 21291379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.
    Mohammed-Saeid W; Chitanda J; Al-Dulaymi M; Verrall R; Badea I
    Pharm Res; 2017 Sep; 34(9):1886-1896. PubMed ID: 28643235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
    Narsineni L; Foldvari M
    Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.
    Gharagozloo M; Rafiee A; Chen DW; Foldvari M
    J Nanobiotechnology; 2015 Sep; 13():62. PubMed ID: 26415935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Engineering as an Approach To Modulate Gene Delivery Efficiency of Peptide-Modified Gemini Surfactants.
    Al-Dulaymi M; Michel D; Chitanda JM; El-Aneed A; Verrall RE; Grochulski P; Badea I
    Bioconjug Chem; 2018 Oct; 29(10):3293-3308. PubMed ID: 30169953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes.
    Badea I; Verrall R; Baca-Estrada M; Tikoo S; Rosenberg A; Kumar P; Foldvari M
    J Gene Med; 2005 Sep; 7(9):1200-14. PubMed ID: 15895387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of amino acid substituted gemini surfactant-based mucoadhesive gene delivery systems for potential use as noninvasive vaginal genetic vaccination.
    Singh J; Michel D; Getson HM; Chitanda JM; Verrall RE; Badea I
    Nanomedicine (Lond); 2015 Feb; 10(3):405-17. PubMed ID: 25707975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New serine-derived gemini surfactants as gene delivery systems.
    Cardoso AM; Morais CM; Cruz AR; Silva SG; do Vale ML; Marques EF; de Lima MC; Jurado AS
    Eur J Pharm Biopharm; 2015 Jan; 89():347-56. PubMed ID: 25513958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model.
    Mohammed-Saeid W; Soudy R; Tikoo R; Kaur K; Verrall RE; Badea I
    J Pharm Pharm Sci; 2018; 21(1):363-375. PubMed ID: 30266136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bis-quaternary gemini surfactants as components of nonviral gene delivery systems: a comprehensive study from physicochemical properties to membrane interactions.
    Cardoso AM; Morais CM; Silva SG; Marques EF; de Lima MC; Jurado MA
    Int J Pharm; 2014 Oct; 474(1-2):57-69. PubMed ID: 25111434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency.
    Cardoso AM; Faneca H; Almeida JA; Pais AA; Marques EF; de Lima MC; Jurado AS
    Biochim Biophys Acta; 2011 Jan; 1808(1):341-51. PubMed ID: 20937247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor D and EGF domains regulate ameloblast differentiation and enamel formation.
    Iwata K; Kawarabayashi K; Yoshizaki K; Tian T; Saito K; Sugimoto A; Kurogoushi R; Yamada A; Yamamoto A; Kudo Y; Ishimaru N; Fukumoto S; Iwamoto T
    J Cell Physiol; 2022 Mar; 237(3):1964-1979. PubMed ID: 34957547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of a gemini surfactant-based biomimetic complex for gene delivery.
    Lu Z; Zongjie G; Qianyu Z; Xueyan L; Kexin W; Baoyan C; Ran T; Fang R; Hui H; Huali C
    Eur J Pharm Biopharm; 2023 Jan; 182():92-102. PubMed ID: 36509322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning optimum transfection of gemini surfactant-phospholipid-DNA nanoparticles by validated theoretical modeling.
    Taheri-Araghi S; Chen DW; Kohandel M; Sivaloganathan S; Foldvari M
    Nanoscale; 2019 Jan; 11(3):1037-1046. PubMed ID: 30569915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.